Eos SENOLYTIX, .
Eos SENOLYTIX, .

Eos SENOLYTIX, .

Measured by AhrefsDR17Ahrefs DR: 17/100. Bottom 25%. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent58Agent Readiness: 58/100. Top 25%. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed57Site Speed: 57/100. Below median. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust74Data Trust: 74/100. Above median. Measured by StartupHub.ai. Median 61.

Develops senolytic drugs to clear senescent cells and promote cellular rejuvenation.

2017ActiveCambridge, United States

About

Eos SENOLYTIX is a longevity biotechnology company developing novel gerotherapeutics that target the fundamental mechanisms of aging. Their lead candidate, PTC-2105, utilizes proprietary MitoXcel™ Technology to restore mitochondrial function and promote the clearance of senescent cells, aiming to improve healthspan and address age-related diseases. This context-dependent approach intervenes at the root cause of aging, mitochondrial dysfunction, to drive systemic improvements.

Key facts

Website
eossenolytix.com
Headquarters
Cambridge, United States
Founded
2017
Business model
B2B

Tech stack

Detected on eossenolytix.com, last scanned 27 Oct 2026.

Frontend
jQuery
Analytics
Google Analytics 4
SEO
All in One SEO
CMS / Builders
WordPress
CDN
Cloudflare
Email provider
Microsoft 365

Eos SENOLYTIX, . scores 17. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is Eos SENOLYTIX, . trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Eos SENOLYTIX, . is 74 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for Eos SENOLYTIX, .